Vytalyou | ₹9 Cr / ~$1M (Pre-Series A)
Investorsync desk1 min read
Deal sheet
₹9 Cr
- Stage
- Pre-Series A
- Sector
- HealthTech
- Announced
- 30 September 2026
Founders: DR. CHIRANTAN BOSE, Dr. Preetesh Bhandari
Founded: 2025
HQ: Mumbai
Sector: Preventive Healthcare / Longevity
What they do
→ Doctor-led longevity and preventive healthcare clinics combining diagnostics, personalised interventions, and medically supervised care
→ Services span pathology, radiology, cardio-respiratory assessment, genetic/cancer screening, gut microbiome evaluation, IV therapies, and regenerative treatments
→ Uses an AI-based Predictive Longevity Evaluation to assess biological ageing and health risks, with doctors reviewing every plan
→ Has served ~1,000 clients since opening its first centre in Powai
The Funding
→ Raised ₹9 Cr in pre-Series A
→ From Chetan Jain (Pharma Dose) and Ratan Jain (Venus Industries)
→ Values Vytalyou at ~₹33 Cr
Why it matters
→ Will expand to Juhu and Worli, taking its Mumbai network to 3 centres, with 10 locations planned nationally
→ India's longevity-care segment is reportedly growing 30%+ annually, with some estimates over 50%
→ Joins a heating-up category alongside Biopeak, Cent, Elevate Now, and Decode Age
→ Founders bring specialist medical credibility (molecular oncology, radiology) rather than a pure wellness-brand angle
Is "longevity medicine" a real category in India, or just premium health check-ups rebranded?
Source: company announcement. First posted on the Investorsync LinkedIn page.